Therapeutic proteasome inhibition in experimental acute pancreatitis

Figure 1 Experimental protocol of acute pancreatitis.

Figure 2 Effects of MG132 on laboratory parameters of acute pancreatitis. ^aP < 0.05; ^bP < 0.01.

Figure 3 Effect of MG132 on mRNA expression of pancreatitis associated protein (PAP) in experimental acute pancreatitis.

Figure 4 Effects of MG132 on measures of oxidative stress in experimental acute pancreatitis. ^aP < 0.05; ^bP < 0.01.

Figure 5 Effects of MG132 on HSP72 expression and IκB degradation in experimental acute pancreatitis. ^aP < 0.05.

Figure 6 Effect of MG132 on NF-κB activation in experimental acute pancreatitis. ^aP < 0.05; ^bP < 0.01.

Figure 7 Effect of MG132 on pancreatic morphological damage in CCK-induced pancreatitis (HE, × 40).